Structure of the Shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3

被引:363
作者
Ling, H
Boodhoo, A
Hazes, B
Cummings, MD
Armstrong, GD
Brunton, JL
Read, RJ [1 ]
机构
[1] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada
[2] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2H7, Canada
[3] Univ Toronto, Dept Med, Toronto, ON M5G 2C4, Canada
[4] Univ Toronto, Dept Microbiol, Toronto, ON M5G 2C4, Canada
关键词
D O I
10.1021/bi971806n
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Shiga-like toxin I (SLT-I) is a virulence factor of Escherichia coli strains that cause disease in humans, Like other members of the Shiga toxin family, it consists of an enzymatic (A) subunit and five copies of a binding subunit (the B-pentamer). The R-pentamer binds to a specific glycolipid, globotriaosylceramide (Gb(3)), on the surface of target cells and thereby plays a crucial role in the entry of the toxin. Here we present the crystal structure at 2.8 Angstrom resolution of the SLT-I B-pentamer complexed with an analogue of the Gb(3) trisaccharide, The structure reveals a surprising density of binding sites, with three trisaccharide molecules bound to each B-subunit monomer of 69 residues. All 15 trisaccharides bind to one side of the B-pentamer, providing further evidence that this side faces the cell membrane. The structural model is consistent with data from site-directed mutagenesis and binding of carbohydrate analogues, and allows the rational design of therapeutic Gb(3) analogues that block the attachment of toxin to cells.
引用
收藏
页码:1777 / 1788
页数:12
相关论文
共 67 条
[1]   INVESTIGATION OF SHIGA-LIKE TOXIN BINDING TO CHEMICALLY SYNTHESIZED OLIGOSACCHARIDE SEQUENCES [J].
ARMSTRONG, GD ;
FODOR, E ;
VANMAELE, R .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (06) :1160-1167
[2]   A PHASE-I STUDY OF CHEMICALLY SYNTHESIZED VEROTOXIN (SHIGA-LIKE TOXIN) PK-TRISACCHARIDE RECEPTORS ATTACHED TO CHROMOSORB FOR PREVENTING HEMOLYTIC-UREMIC SYNDROME [J].
ARMSTRONG, GD ;
ROWE, PC ;
GOODYER, P ;
ORRBINE, E ;
KLASSEN, TP ;
WELLS, G ;
MACKENZIE, A ;
LIOR, H ;
BLANCHARD, C ;
AUCLAIR, F ;
THOMPSON, B ;
RAFTER, DJ ;
MCLAINE, PN .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) :1042-1045
[3]   CHOLESTEROL AND THE GOLGI-APPARATUS [J].
BRETSCHER, MS ;
MUNRO, S .
SCIENCE, 1993, 261 (5126) :1280-1281
[4]   METHODS AND PROGRAMS FOR DIRECT-SPACE EXPLOITATION OF GEOMETRIC REDUNDANCIES [J].
BRICOGNE, G .
ACTA CRYSTALLOGRAPHICA SECTION A, 1976, 32 (SEP1) :832-847
[5]   FREE R-VALUE - A NOVEL STATISTICAL QUANTITY FOR ASSESSING THE ACCURACY OF CRYSTAL-STRUCTURES [J].
BRUNGER, AT .
NATURE, 1992, 355 (6359) :472-475
[6]  
BRUNGER AT, 1992, XPLOR VERSION 3 1 SY
[7]  
BRUNTON JL, 1990, BACTERIA, V11, P377
[8]   RISK-FACTORS FOR THE PROGRESSION OF ESCHERICHIA-COLI O157-H7 ENTERITIS TO HEMOLYTIC-UREMIC SYNDROME [J].
CIMOLAI, N ;
CARTER, JE ;
MORRISON, BJ ;
ANDERSON, JD .
JOURNAL OF PEDIATRICS, 1990, 116 (04) :589-592
[9]   Phenylalanine 30 plays an important role in receptor binding of verotoxin-1 [J].
Clark, C ;
Bast, D ;
Sharp, AM ;
StHilaire, PM ;
Agha, R ;
Stein, PE ;
Toone, EJ ;
Read, RJ ;
Brunton, JL .
MOLECULAR MICROBIOLOGY, 1996, 19 (04) :891-899
[10]   INTERACTION OF VIBRIO-CHOLERAE ENTEROTOXIN WITH CELL-MEMBRANES [J].
CUATRECASAS, P .
BIOCHEMISTRY, 1973, 12 (18) :3547-3558